India Approves First Dengue Vaccine QDENGA for Public Use
| Key Aspect | Details |
|---|---|
| Vaccine Name | QDENGA (Developed by Takeda Biopharmaceuticals) |
| Approval Authority | Drug Controller General of India (DCGI) |
| Target Age Group | 4-60 years (No pre-vaccination screening required) |
| Dengue Strains Covered | All four (DENV-1, DENV-2, DENV-3, DENV-4) |
| Dosage | Two doses |
| Current Prevention Methods | Mosquito control, public education, surveillance, symptomatic treatment. |